KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Deferred Taxes (2016 - 2017)

Historic Deferred Taxes for Bio-Rad Laboratories (BIO) over the last 3 years, with Q3 2017 value amounting to -$5.3 million.

  • Bio-Rad Laboratories' Deferred Taxes fell 14265.55% to -$5.3 million in Q3 2017 from the same period last year, while for Sep 2017 it was $10.2 million, marking a year-over-year increase of 13133.18%. This contributed to the annual value of -$6.4 million for FY2015, which is 158.73% down from last year.
  • According to the latest figures from Q3 2017, Bio-Rad Laboratories' Deferred Taxes is -$5.3 million, which was down 14265.55% from $2.9 million recorded in Q2 2017.
  • Bio-Rad Laboratories' Deferred Taxes' 5-year high stood at $12.5 million during Q3 2016, with a 5-year trough of -$5.3 million in Q3 2017.
  • Over the past 3 years, Bio-Rad Laboratories' median Deferred Taxes value was -$1.7 million (recorded in 2015), while the average stood at -$73375.0.
  • As far as peak fluctuations go, Bio-Rad Laboratories' Deferred Taxes soared by 56018.35% in 2016, and later crashed by 14265.55% in 2017.
  • Quarter analysis of 3 years shows Bio-Rad Laboratories' Deferred Taxes stood at -$4.0 million in 2015, then skyrocketed by 409.63% to $12.5 million in 2016, then tumbled by 142.66% to -$5.3 million in 2017.
  • Its Deferred Taxes stands at -$5.3 million for Q3 2017, versus $2.9 million for Q2 2017 and $163000.0 for Q1 2017.